Les promesses de la médecine de précision dépendent de nouvelles solutions technologiques pour le diagnostic. Dans l’aire post-génomique, les approches de biologie synthétique pour la médecine apportent de nouvelles façon de sonder, monitorer et interfacer la physiopathologie humaine. Émergeant en tant que champ scientifique mature dont la transition clinique s’accélère, la biologie synthétique peut être utilisée pour appliquer des principes d’ingénierie afin de concevoir et construire des systèmes biologiques comprenant des spécifications cliniques. Une application particulièrement intéressante est de développer des outils diagnostiques polyvalents, programmables et intelligents étroitement interconnectés avec la thérapie. Cette thèse présente de nouveaux concepts et approches d’ingénierie pour concevoir des dispositifs biosynthétiques capable d’interfacer les maladies humaines dans des échantillons cliniques en exploitant du traitement de signal au niveau biomoléculaire, à la lumière d’un besoin croissant en termes de capacités et de robustesse. Cette thèse s’intéresse en premier lieu à l’ingénierie de circuits synthétiques de gènes, reposant sur les portes logiques à integrases, pour intégrer des opérations modulaires et programmables de biodétéction de biomarqueur associées à des algorithmes de décisions au sein de population de bactéries. Elle s’intéresse ensuite à des méthodologies systématiques dites bottom-up, pour programmer des protocellules synthétiques microscopiques, capables d’exécuter des opérations de biodétéction médicale et de biocomputation. Nous décrivons le développement de méthodes simples de fabrications microfluidique associées à des solutions pour implémenter des opérations Booléenne complexes en utilisant de circuits biochimiques synthétiques. Cette contribution s’élargit aussi à la caractérisation de l’espace de conception de protocellules à l’aide d’approches de design assisté par ordinateur, ainsi que à l’analyse de preuves mathématiques et biologiques pour l’utilisation de protocellules comme des dispositifs universels de calcul. L’articulation des principes biologiques fondamentaux avec les implications médicales concernant les dispositifs biosynthétiques développés dans ce travail, a été jusqu’à la validation clinique, et initie de nouveaux modèles pour le développement de diagnostics de nouvelle génération. Ce travail prévoit que la biologie synthétique est en train de préparer le future de la médecine, en supportant et accélérant le développement de diagnostics avec de nouvelles capacités, apportant un progrès biotechnologique direct depuis le laboratoire de biologie clinique jusqu’au patient. / The promise for real precision medicine is contingent on novel technological solutions to diagnosis. In the post-genomic era, synthetic biology approaches to medicine provide new ways to probe, monitor and interface human pathophysiology. Emerging as a mature field increasingly transitioning to the clinics, synthetic biology can be used to apply engineering principles to design and build biological systems with clinical specifications. A particularly tantalizing application is to develop versatile, programmable and intelligent diagnostic devices closely interconnected with therapy. This thesis presents novel engineering concepts and approaches to design synthetic biological devices interfacing human diseases in clinical samples through biomolecular digital signal processing, in light of a need for dramatic improvements in capabilities and robustness. It addresses primarily the engineering of synthetic gene circuits through integrase based digital genetic amplifiers and logic gates, to integrate modular and programmable biosensing of biomarkers and diagnostic decision algorithms into bacteria. It then investigates systematic bottom-up methodologies to program microscale synthetic protocells performing medical biosensing and biocomputing operations. We demonstrate streamlined microfluidic fabrication methods and solutions to implement complex Boolean operation using integrated synthetic biochemical circuits. This contribution also extends to the characterization of protocell design space through novel computer assisted design frameworks, as well as the analysis of mathematical and biological evidence for universal protocellular biocomputing devices. The articulation of biological governing principles and medical implications for the synthetic devices developed in this work was further validated in the clinic, and initiates new models towards next-generation diagnostics. This work envisions that synthetic biology is preparing the future of medicine, supporting and speeding up the development of diagnostics with novel capabilities to bring direct improvement in biotechnologies from the clinical lab to the patient.

Formation of segments during vertebrate embryogenesis is regulated by a biological clock. Models and experimental data indicate that the core of this clock consists of a cell- autonomous single cell oscillator. This oscillator likely involves a genetic feedback loop of transcriptional repressors belonging to the hairy gene family. In zebrafish, three her genes, her1, hes6 and her7, have been identified as core oscillator components. The main purpose of this project was to study the molecular mechanism of the hairy gene negative feedback oscillator in single cells. To determine whether a single cell oscillator is part of the zebrafish segmentation clock, a cell dissociation protocol was established to track the expression of Her1 ex vivo. Upon dissociation, Her1 expression continued to oscillate for up to three cycles. The period of oscillations was significantly slower than that of the segmentation clock, but appears to speed up in the presence of serum. To test whether the hairy gene interactions are sufficient to generate oscillations in single cells, a protocol was established that uses synthetic biology principles to design, construct and characterize hairy gene networks in yeast. First a library of network parts, containing hairy genes, promoters and Her binding sites was generated and subsequently assembled into simple devices to test their functionality in yeast. The three core oscillator components, Her1, Hes6 and Her7, were characterized and optimized for expression in yeast. In the SWITCH-OFF assay, the Her1 protein, modified with a MigED yeast repressor domain, was found to function as a transcriptional repressor in yeast, while Hes6 with the same modification can not. The dissociation of segmentation clock cells provides the first direct evidence that single cell oscillators exist in zebrafish. In this system, oscillator dynamics can be studied without the interactions of higher level clock components. In parallel, establishing a yeast chassis for hairy gene networks provides a novel technique to directly test predicted oscillator mechanisms by constructing them ’bottom up’.

This study is part of a project which aims to understand evolution of genetic code together with structural and functional analysis of prebiotic proteins. The repertoire of amino acids in the first proteins was probably developing in time and it influenced the development of structure and function of today's proteins. First amino acid alphabet was apparently only half of the size of present alphabet, which contains twenty amino acids. These ten amino acids were probably prebiotically available from endogenous and exogenous sources. This work includes cell-free expression and purification of two randomized protein libraries (containing approximately 1011 variants) with various amino acid composition and following comparison of their propensity to form secondary (using circular dichroism) and tertiary (using proteolytical analysis of sequences) structures. First library contains only ten probably prebiotically available amino acids; second library contains all twenty amino acids in today's genetic code. This project could help us understand benefits of genetic code expansion in terms of developing structure in protein sequences. The whole research could theoretically contribute a few basic questions not only in the fields of protein evolution but also in areas of synthetic biology or protein...

Das stäbchenförmige Bakterium Escherichia coli teilt sich in zwei gleich große Tochterzellen. Dies ist nur möglich, wenn sich die Zelle in der Mitte teilt. Bei E. coli wird die Zellteilung durch den Zusammenschluss der FtsZ-Proteine an der Membran zum Z-Ring eingeleitet. Topologische Regulierung des Z-Ringes erfolgt durch räumlich-zeitliche Oszillationen von Min-Proteinen zwischen den beiden Zellpolen. MinC, MinD und MinE binden an und lösen sich von der Membran unter Hydrolyse von ATP und in antagonistischer Art und Weise, was zu einer alternierenden Ansammlung von MinC und MinD an den Zellpolen führt. Gemittelt über die Zeit ergibt sich somit ein MinD-Verteilungsprofil, das maximale Konzentration an den Zellpolen und ein Minimum in der Zellmitte aufweist. MinC bindet an MinD und folgt somit seiner Verteilung. Der Zusammenschluss von FtsZ-Proteinen wird durch MinC unterbunden, und somit kann sich der Z-ring nur an einer Position herausbilden, die ein Minimum an MinC aufweist - der Zellmitte. Das Min-system wurde in der Vergangenheit auch mit einem in-vitro-Ansatz untersucht, indem Min-Proteine in künstliche, aufliegende Lipiddoppelschichten (supported lipid bilayers, SLB) rekonstitutiert wurden. Dabei bildeten die Min-Proteine kein oszillierendes Muster aus, sondern organisierten sich vielmehr in parallelen und propagierenden Wellen (Loose, 2008, Science, 320). In diesen in-vitro-Experimenten war das Membransubstrat wesentlich größer als die Wellenlänge der Min-Proteinwellen. In vivo hingegen ist die Länge der Zelle in der gleichen Größenordnung wie die charakteristische Länge des Oszillationsmusters der Min-Proteine. Daher war es das Ziel dieser Arbeit, den Einfluß einer beschränkten Fläche und geometrischer Formgebung der künstlichen Lipiddoppelschichten auf die Wellenpropagation der Min-Protein zu untersuchen. Flächige Beschränkung künstlicher Membranen erfolgte durch Mikrostrukturtechnologie. Deckglässchen wurden mit einer Goldschicht und mikroskopischen Aussparungen unterschiedlicher geometrischer Formen strukturiert. Funktionale SLBs bildeten sich nur auf Glasflächen ohne Goldbeschichtung aus. Nach der Rekonstitution der Min-Proteine, organisierten sich diese auf den Membranstücken in parallele Wellen. Dabei bestimmte die flächige Beschränkung der künstlichen Membranen die Ausbreitungsrichtung der Min-Proteinwellen. Min-Proteinwellen konnten entlang gekrümmter Membranstreifen, in Ring- und sogar in Slalomstrukturen geleitet werden. In geraden, länglichen Strukturen richteten sich die Wellen entlang der längsten Achse aus. Kopplung von Proteinwellen auf räumlich getrennten Membranstücken in Abhängigkeit des Abstandes und des sogenannten Molecular Crowdings in der wässrigen Lösung konnte ebenfalls beobachtet werden. Diese Kopplung ist ein Indiz für inhomogene Proteinverteilungen in der Lösung oberhalb der Membran. Desweiteren konnten Min-Proteinwellen auch in diversen dreidimensionalen künstlichen Membranen rekonstitituiert werden. Im Wildtyp von E. coli ähneln die Min-Proteindynamiken der einer Oszillation mit einer charakteristischen Länge von 5 µm. Auf SLBs, bilden Min-Proteine Wellen mit einer Wellenlänge aus, die ca. zehnmal größer ist als in vivo. Dieser Unterschied zwischen der in-vivo- und der in-vitro-Welt wurde untersucht und diskutiert. In vitro konnte die Wellenlänge um 50 % durch Erhöhung des Molecular Crowding in der Lösung sowie um 33 % durch Temperaturerhöhung verkleinert werden. Das oszillierende Muster könnte dahingegen eine Folge der Kompartimentierung sein. Erste Versuche, das Min-System in geschlossene Membrankompartimente zu rekonstitutieren, wurden getestet. / Escherichia coli, a rod-like bacterium, divides by binary fission. Cell division into two daughter cells of equal size requires that fission takes place at a midcell position. In E. coli, cell division is initiated by assembly of the FtsZ-proteins at the inner membrane to the Z-ring. Topological regulation of the Z-ring is achieved by spatiotemporal pole-to-pole oscillations of Min-proteins. MinC, MinD and MinE bind to and detach from - under hydrolysis of ATP - the membrane in an antagonistic manner leading to an alternating accumulation of MinC and MinD at the cell poles. Averaged over time, the distribution profile of MinD exhibits maximal concentration at the cell poles and a minimum at the cell center. MinC binds to MinD and thus follows its distribution. FtsZ assembly is inhibited by MinC and therefore the Z-ring can only form at a cell position low in MinC - at the cell center. In the past, the Min-system was also investigated in an in vitro approach by reconstitution of Min-proteins into a supported lipid bilayer (SLB). Here, Min-proteins did not self-organize into an oscillatory pattern but into parallel and propagating waves (Loose, 2008, Science, 320). In this in vitro assay, the membrane substrate was infinitely large compared to the wavelength. However, in vivo, the cell length is on the same order of magnitude as the respective length scale of the oscillatory pattern of Min-proteins. Therefore, we wished to investigate the effect of lateral confinement and geometric structuring of artificial lipid bilayers on the Min-protein wave propagation. Lateral confinement of artificial membranes was achieved by microfabrication technology. Glass slides were patterned by a gold coating with microscopic windows of different geometries, and functional SLBs were only formed on uncoated areas. Upon reconstitution, Min-proteins organized into parallel waves on the geometric membrane patches. Confinement of the artificial membranes determined the direction of propagation of Min-protein waves. Min-protein waves could be guided along curved membrane stripes, in rings and even along slalom-geometries. In elongated membrane structures, the protein waves always propagate along the longest axis. Coupling of protein waves across spatially separated membrane patches was observed, dependent on gap size and level of molecular crowding of the aqueous media above the bilayer. This indicates the existence of an inhomogeneous and dynamic protein gradient in the solution above the membrane. Furthermore, reconstitution of Min-protein waves in various three-dimensional artificial membranes was achieved. In wild-type E. coli, Min-protein dynamics resemble that of an oscillation with a characteristic length scale of 5 µm. On supported lipid bilayers, Min-proteins self-organize into waves with a wavelength approximately 10-fold larger than in vivo. These discrepancies between the in vivo and in vitro world were investigated and discussed. In vitro, the wavelength could be decreased by a factor of 50 % by increase of the molecular crowding in solution and by 33 % through temperature increase. The oscillatory pattern is thought to be a consequence of compartmentalization and first attempts to encapsulate the Min-system in closed bilayer compartments are presented.

As an inspiration from nature, polymeric vesicles can be formed from amphiphilic block-copolymers. These vesicles are called polymersomes and have applications in drug delivery and as nanoreactors. Within this thesis, photo cross-linked and pH sensitive polymersomes were synthesized, characterized and applied on cells as well as bionanoreactors. The stability due to the crosslinking yielded polymersomes which show a distinct and reproducible swelling upon repeated pH changes. If the non cross-linked vesicles were exposed to a plasma-cleaned surface, they formed a tethered singly and multiple bilayers. Upon studying these membranes, they turned out to harden upon crosslinking and showed a completely non-fluid behaviour. Additionaly, the polymersome-cell interactions were studied and yielded a high influence of the crosslinking conditions on cellular toxicity. If crosslinked for a long time in a phosphate-free enviroment, the polymersomes proved to be least toxic. Finally, an enzyme was incorporated into the polymersomes to create bionanoreactors. Due to the pH sensitivity and swelling, the vesicles created yielded a pH controlled nanoreactor with enzymatic activity and a swollen, e.g. acidic, state only.

<p>  Non-model microorganisms offer a wealth of biotechnological potential that may be leveraged to address a variety of global grand challenges. These include challenges in carrying out complex or altogether new chemistries, discovery and production of bioactive molecules, sustainable production of biochemicals and bioproducts from renewable feedstocks, and improving agricultural practices for responsible management of carbon. Specifically, using renewable plant biomass as a substrate for production of fuels and or chemicals offers a near ubiquitous supply that does not compete with food or petrochemicals. Alternatively, identifying new natural products will be essential to addressing the ever-increasing occurrence of antibiotic resistance. Non-model organisms may provide elegant solutions to many of these challenges, whether by possessing new or more efficient strategies to depolymerize lignocellulose, by encoding enzymes with increased stabilities and or specific activities, or perhaps by containing rich biosynthetic capabilities for production of previously unidentified natural products, among others. Yet efforts to leverage non-model microorganisms for their diverse biotechnological potential remain limited to a variety of often difficult, yet not insurmountable challenges.</p> <p>     In this work, I propose anaerobic gut fungi (Neocallimastigomycota) as a robust microbial system that may be leveraged to efficiently depolymerize crude lignocellulose, increase animal nutrition, or identify novel natural products. To this end, I detail the first chromosomally resolved genome assembly of anaerobic fungi (<em>Piromyces communis </em>var. <em>indianae</em> UH3-1). I investigate the genome organization of this isolate and describe how acquisition of Carbohydrate Active EnZymes (CAZymes) contribute to the robust lignocellulolytic activity of gut fungi. I then detail efforts to build a nascent genetic engineering toolbox for these anaerobic organisms. With the acquisition of the first chromosomally resolved genome assemblies, I identify a basic set of genetic parts needed for a genetic engineering toolkit. I show these parts are functional and detail methods to enable higher throughput testing in vivo. I subsequently detail efforts to construct the first preliminary CRISPR tools for anaerobic fungi as these will be essential to establish precise DNA targeting in future strain engineering efforts. I then describe the role of epigenetics in anaerobic fungi, detailing the extent to which it may be leveraged to control gene expression. Finally, I provide a discussion of this work and describe how it may guide future efforts to domesticate these organisms. Collectively, this work provides the first chromosomally resolved genome assembly as a resource for the community, along with genetic tools and techniques to begin domesticating these non-model organisms. Importantly, this work reveals that despite the challenges associated with anaerobic microbes of relatively high complexity, they are not insurmountable, and thus efforts to domesticate them are feasible.</p>

Synthetic biology has ushered in a new age of molecular biology with the aim towards practical developments in disciplines ranging from medicine, agriculture, and industry. Presently, it remains difficult to manipulate the genomes of many organisms due to lack of genetic tools. These problems can be circumvented by cloning large fragments of DNA into strains where many genetic tools are in place, such as Saccharomyces cerevisiae. However, this organism is unable to directly transfer cloned DNA to other organisms and is unable to stably maintain DNA with a G+C content >40%. Many organisms relevant in biotechnology often have G+C content DNA >60%, and therefore are difficult to engineer. Here, the soil bacteria Sinorhizobium meliloti was chosen as a host strain to clone and manipulate large fragments of high G+C content DNA. S. meliloti is a Gram-negativeα-proteobacteria that forms symbiotic relationships with legumes to fix nitrogen. It has a multi-partite genome with a G+C content of 62.7% that includes a chromosome (3.65 Mb), the pSymA (1.35 Mb), and pSymB (1.68 Mb) replicons. A restriction endonuclease hsdR mutant strain lacking pSymA and pSymB was created and used in this study. Multi-host shuttle (MHS) vectors were constructed that allow for direct transfer and maintenance of DNA in E. coli, S. cerevisiae, and P. tricornutum. Characterization of strains was conducted to determine transduction, conjugation, and transformation frequencies, as well as stability of MHS plasmids. Furthermore, a proof-of-concept experiment was conducted to clone large plasmids (70-205 kb) with G+C content >58% via site-specific recombination at a landing pad in the MHS vector, which was then verified using colony PCR. This work demonstrates the usefulness of S. meliloti containing a MHS vector for cloning of large fragments with high G+C content DNA, a technology that may be used for several applications in both applied and basic research. / Thesis / Master of Science (MSc) / Synthetic biology is an emerging field that incorporates principles of molecular biology and engineering for the design and construction of biological systems for application in medicine, agriculture, and industry. Presently, it remains difficult to modify genomes of several organisms due to lack of available techniques. Yeast is currently used for the modification of large DNA pieces, however it is unable to transfer and maintain modified DNA with high G+C content. Here, the bacteria Sinorhizobium meliloti was used as a host organism to conduct genetic engineering due to its ability to maintain large DNA pieces with a high G+C content. Characterization experiments were conducted to assess the efficiency of this organism for this task. Using this strain, a proof-of-concept experiment to demonstrate the uptake and maintenance of large, high G+C DNA pieces was completed. This technology may be useful in biotechnology applications for engineering of large DNA pieces from industrially relevant organisms.

Ce mémoire traite des représentations du vivant portées par l’imaginaire sociotechnique de la biologie de synthèse. Domaine technoscientifique en pleine expansion, elle a comme objectif de fabriquer des entités biologiques détenant une application commerciale. En plus de ses visées économiques, les promoteurs de la biologie de synthèse annoncent qu’elle constitue une solution aux enjeux engendrés par la crise écologique. Ce type de promesse étant moins étudié par la sociologie des sciences et des technologies, ce présent mémoire fera lumière sur cet enjeu. Je montrerai que la biologie de synthèse s’inscrit dans le modèle bioéconomique qui implique une mise en ressource à large échelle globale des processus biologiques. L’imaginaire de la biologie de synthèse reconduit ainsi une double promesse : poursuivre le modèle de développement industriel tout en évacuant les limites écologiques qui s’y posent. Avec une analyse des discours médiatiques et publicitaires relatifs aux promesses écologiques de la biologie de synthèse, je démontrerai que son imaginaire s’appuie sur une représentation machinique et informationnelle du vivant. Par le fait même, cette analyse montrera que la volonté de mettre les processus biologiques en ressource se décline elle-même en deux tendances. D’une part, le vivant est posé dans les termes d’une matière première inerte et malléable. D’autre part, il est représenté comme une entité active qui peut être mise au travail. L’imaginaire de la biologie de synthèse relève donc d’une radicalisation de la volonté d’englober les processus biologiques dans la production industrielle. Les promesses écologiques de ce domaine apparaissent subordonnées à cette visée. / This thesis focuses on the representations of the living carried by the sociotechnical imaginary of synthetic biology. Synthetic biology is a fast-growing technoscientific field whose main objective is to manufacture biological entities with commercial applications. In addition to its economic aims, promoters of synthetic biology claim that it represents a solution to the challenges posed by the ecological crisis facing contemporary societies. As this type of promise is less studied by the sociology of science and technology, this thesis will shed light on this issue. I will show that synthetic biology is part of the bioeconomy, which proposes the large-scale transformation of biological processes into valuable resources. The imaginary of synthetic biology thus makes a double promise : to continue the industrial development model while bypassing its ecological limits. Through an analysis of media and advertising discourse relating to the ecological promises of synthetic biology, I will demonstrate that its imaginary underpins a machine-like, informational representation of living matter. Furthermore, this analysis will show that the desire to turn biological processes into resources underlies two trends. On the one hand, living matter is posited in terms of an inert, malleable raw material. On the other, it is represented as an active entity that can be put to work. The sociotechnical imaginary of synthetic biology thus reflects a radicalization of the desire to incorporate biological processes into industrial production. The ecological promises of this field appear subordinate to this aim.

Mucosal passive immunization is the transfer of active antibodies from one organism to the mucosal surfaces of another organism for preventing or treating infectious diseases. Mucosal passive immunization has a great potential for the prevention and treatment of enteric infections like Rotavirus, which causes more than 114 million episodes of diarrhoea annually with a death toll of more than 450.000 per year. However, the high cost of recombinant antibodies with the current manufacturing systems based on mammalian cells hampers the production of the high antibody quantities required for passive immunization strategies. Alternative expression platforms such as plants could provide higher scalability and reduced costs. Moreover, the use of edible plant organs, which are Generally¿Regarded¿As¿ Safe (GRAS), could reduce manufacturing costs even further by easing the requirements for antibody purification. We analyze here the feasibility of utilizing fruits as inexpensive biofactories of human antibodies that can be orally delivered as crude extracts or partially purified formulations in mucosal passive immunization strategies. In the first section of this thesis, the construction of tomato plants producing a model human Immunoglobulin A (IgA) against rotavirus in their fruits is described. As a result, an elite homozygous line was obtained whose fruits produced on average 41 ¿g of IgA per gram of fresh weigh, equivalent to 0.69 mg IgA per gram of dry tomato powder. Minimally processed products derived from IgA¿expressing tomatoes were shown to strongly inhibit virus infection in an in vitro neutralization assay. Moreover, in order to make IgA¿expressing tomatoes easily distinguishable from wild¿type tomatoes, they were sexually crossed with a transgenic tomato line expressing the genes encoding Antirrhinum majus Rosea1 and Delila transcription factors, which confer purple colour to the fruit. The resulting transgenically¿labelled purple tomatoes contained not only high levels of recombinant neutralizing human IgA but also increased amounts of anthocyanins. In the second section of the thesis the composition of IgA¿expressing tomatoes was analyzed in search of possible unintended effects that could compromise the GRAS status of the final product. To this end, transgenic IgA¿tomatoes were compared with wild type tomatoes and also commercial tomato varieties using proteomic and metabolomic approaches. 2D¿DIGE gels coupled with LC¿MSMS for protein identification showed that all the uptrend differential proteins detected corresponded only to immunoglobulin chains or antibody fragments. On the other hand, non¿targeted metabolite data obtained by UPLC¿MS / Juárez Ortega, P. (2014). Production of recombinant Immunoglobulin A in plants for passive immunotherapy [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/37015

In order to decrease our dependence on non-renewable petrochemical resources, it is urgently required to establish sustainable biomass-based biorefineries. Replacing fossil fuels with renewable biomass as a raw feedstock for the production of chemicals and biofuels is a main driving force of biorefinering. Almost all kinds of biomass can be converted to biochemicals, biomaterials and biofuels via continuing advances on conversion technologies. In vitro synthetic biology is an emergent biomanufacturing platform that circumvents cellular constraints so that it can implement some biotransformations better than whole-cell fermentation, which spends a fraction of energy and carbon sources for cellular duplication and side-product formation. In this work, the in vitro synthetic (enzymatic) biosystem is used to produce a future carbon-neutral transportation fuel, hydrogen, and two high-value chemicals, a sugar phosphate and a highly marketable sweetener, representing a new portfolio for new biorefineries. Hydrogen gas is a promising future energy carrier as a transportation fuel, offering a high energy conversion efficiency via fuel cells, nearly zero pollutants produced to end users, and high mass-specific and volumetric energy densities compared to rechargeable batteries. Distributed production of cost-competitive green hydrogen from renewable biomass will be vital to the hydrogen economy. Substrate costs contribute to a major portion of the production cost for low-value bulk biocommodities, such as hydrogen. The reconstitution of 17 thermophilic enzymes enabled to construct an artificial enzymatic pathway converting all glucose units of starch, regardless of the branched and linear contents, to hydrogen gas at a theoretic yield (i.e., 12 H2 per glucose), three times of the theoretical yield from dark microbial fermentation. Using a biomimetic electron transport chain, a maximum volumetric productivity was increased by more than 200-fold to 90.2 mmol of H2/L/h at a high starch concentration from the original study in 2007. In order to promote economics of biorefineries, the production of a sugar phosphate and a fourth-generation sweetener is under development. D-xylulose 5-phosphate (Xu5P), which cannot be prepared efficiently by regular fermentation due to the negatively charged and hydrophilic phosphate groups, was synthesized from D-xylose and polyphosphate via a minimized two-enzyme system using a promiscuous activity of xylulose kinase. Under the optimized condition, 32 mM Xu5P was produced from 50 mM xylose and polyphosphate, achieving a 64% conversion yield, after 36 h at 45 °C. L-arabinose, a FDA-approved zero-calorie sweetener, was produced from D-xylose via a novel enzymatic pathway consisting of xylose isomerase, L-arabinose isomerase and xylulose 4-epimerase (Xu4E). Promiscuous activity of Xu4E, a monosaccharide C4-epimerase, was discovered for the first time. Directed evolution of Xu4E enabled to increase the catalytic function of C4-epimerization on D-xylulose as a substrate by more than 29-fold from the wild-type enzyme. Together, these results demonstrate that the in vitro synthetic biosystem as a feasible biomanufacturing platform has great engineering, and can be used to convert renewable biomass resources to a spectrum of marketable products and renewable energy. As future efforts are addressed to overcome remaining challenges, for example, decreasing enzyme production costs, prolonging enzyme lifetime, engineering biomimetic coenzymes to replace natural coenzymes, and so on. This in vitro synthetic biology platform would become a cornerstone technology for biorefinery industries and advanced biomanufacturing (Biomanufacturing 4.0). / Ph. D. / The carbon cycle is the circulation and transformation of carbon back and forth between living things and the environment. With the fixed amount of carbon dioxide in the atmosphere, the carbon cycle has been in the balance of exchanges between living things and the environment. As we evolve with increasing demand on crude oil, however, significant amounts of carbon are being released into the atmosphere much faster than they would have been released naturally. This rapid release is the primary cause of currently observed global warming. In order to decrease our dependence on petrochemical products, the biorefinery was introduced as the sustainable processing of biomass into a spectrum of alternatives to products from petrochemical refineries. Almost all kinds of biomass can be converted to biochemicals, biomaterials and biofuels via continuing advances on conversion technologies. In vitro synthetic biology is an emergent biomanufacturing platform that circumvents whole cell’s constraints, so that it can implement some biotransformations better than whole-cell fermentation spending a significant fraction of energy and carbon sources for cellular duplication and side-product formation. In this work, the in vitro synthetic (enzymatic) biosystem is used to produce a future carbon-neutral transportation fuel, hydrogen gas, and two high-value chemicals, a sugar phosphate and a highly marketable sweetener, representing a new portfolio for new biorefineries. Hydrogen gas is a promising energy carrier as a transportation fuel, offering a high energy conversion efficiency via fuel cells, nearly zero pollutants produced to end users, and high mass-specific and volumetric energy densities compared to rechargeable batteries. Distributed production of cost-competitive green hydrogen will be vital to the hydrogen economy. We demonstrated an in vitro 17-thermophilic enzyme pathway that can convert all glucose units of starch to hydrogen a theoretic yield, which is three times of the theoretical yield from dark microbial fermentation. D-xylulose 5-phosphate (Xu5P), which cannot be prepared efficiently by regular fermentation due to the negatively charged and hydrophilic phosphate groups, was synthesized from D-xylose and polyphosphate via a minimized two-enzyme system using a promiscuous activity of xylulose kinase. This minimal in vitro enzymatic pathway was optimized for improved conversion yield and productivity. L-arabinose, a FDA-approved zero-calorie sweetener, was also produced from D-xylose via a novel enzymatic pathway consisting of xylose isomerase, L-arabinose isomerase and hypothetical enzyme xylulose 4-epimerase (Xu4E), a monosaccharide 4-epimerase that can convert D-xylulose to L-ribulose. Xu4E activities due to substrate promiscuity of some natural 4-epimerases were discovered for the first time. Three rounds of directed evolution have been conducted to increase the catalytic function of carbon 4-epimerization on D-xylulose. As the result, the catalytic activity of Xu4E was improved by more than 29-fold from the wild-type enzyme.